morab-066
mAbexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01761240)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Coagulation factor IIIINHIBITOR
F3 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- morab-066
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01761240 | Phase 1 | Jun 1, 2013 | Morphotek, SCRI Development Innovations, University of Oklahoma |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Morphotek | For profit | 1 | 1 | 1 | 2013 |
| SCRI Development Innovations | For profit | 1 | 0 | 1 | 2013 |
| University of Oklahoma | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1